Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-09

Clinical Trial Update: Diclofenac Dose Response Study [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to evaluate the dose-response effects of diclofenac in people with alcohol use disorder; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diclofenac (diclofenac)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Alcohol Use Disorder (AUD), Alcohol-Related Disorders | Phase 1 | Status: RECRUITING